Home > Drug Search >
  • company_query: Agenix
  •   > 
Drug Filter
Category:
chemistry (14) biology (21)
Status:
Approved (2) BLA Filing (1) Phase Ⅲ (2) Phase Ⅱ (16) Phase Ⅰ (13) IND Filing (1)
Clinical Stage:
Pending (4) Active (25) Discontinued (4)
Bio-Type:
Gene therapy (1) Cell therapy (1) Vaccine (11) Recombinant cytokines (1) Recombinant hormone (1) Whole antibody (3)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Advanced or metastatic breast cancer (1) Alzheimer's disease (AD) (2) Asthma (2) Atopic dermatitis (1) Bladder cancer (1) Breast cancer (2) Deep vein thrombosis (DVT) (1) Depression (1) Diabetic macular edema (1) Essential hypertension-重复 (1) Follicular lymphoma (1) Gastric cancer (2) Cytomegalovirus infections (1) HBV infection (1) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Hypertension (1) Ischaemia (1) Fissure in ano (1) Influenza virus infection (2) Lung cancer (2) Melanoma (3) Neuropathic pain (1) Non-Hodgkin’s lymphoma (NHL) (1) NSAID-associated gastric ulcer (1) Psoriasis (1) Pulmonary embolism (1) Renal cell carcinoma (1) Solid tumours (3) Leber congenital amaurosis (1) Tuberculosis (1) Type 2 diabetes (2) Ulcerative colitis (1) Colorectal cancer (2) Metastatic non-small cell lung cancer (1) Relapsed or refractory malignant lymphoma (1) Malaria (1) Hematological cancer (2) Glioblastoma (1) Corneal disorders (1) Diabetic neuropathy (1) Liver cancer (1) Hemorrhoids (1) Ebola virus disease (EVD) (1) Inflammation (1) Stomatitis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top